Cargando…
PCSK9 Plasma Concentrations Are Independent of GFR and Do Not Predict Cardiovascular Events in Patients with Decreased GFR
BACKGROUND: Impaired renal function causes dyslipidemia that contributes to elevated cardiovascular risk in patients with chronic kidney disease (CKD). The proprotein convertase subtilisin/kexin type 9 (PCSK9) is a regulator of the LDL receptor and plasma cholesterol concentrations. Its relationship...
Autores principales: | Rogacev, Kyrill S., Heine, Gunnar H., Silbernagel, Günther, Kleber, Marcus E., Seiler, Sarah, Emrich, Insa, Lennartz, Simone, Werner, Christian, Zawada, Adam M., Fliser, Danilo, Böhm, Michael, März, Winfried, Scharnagl, Hubert, Laufs, Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723078/ https://www.ncbi.nlm.nih.gov/pubmed/26799206 http://dx.doi.org/10.1371/journal.pone.0146920 |
Ejemplares similares
-
Distinct immunologic effects of different intravenous iron preparations on monocytes
por: Fell, Lisa H., et al.
Publicado: (2014) -
Combined Use of Serum Uromodulin and eGFR to Estimate Mortality Risk
por: Yazdani, Babak, et al.
Publicado: (2021) -
Markers of cholesterol synthesis to cholesterol absorption across the spectrum of non‐dialysis CKD: An observational study
por: Emrich, Insa E., et al.
Publicado: (2021) -
Plasma biomarkers outperform echocardiographic measurements for cardiovascular risk prediction in kidney transplant recipients: results of the HOME ALONE study
por: Emrich, Insa E, et al.
Publicado: (2021) -
Massive analysis of cDNA Ends (MACE) and miRNA expression profiling identifies proatherogenic pathways in chronic kidney disease
por: Zawada, Adam M, et al.
Publicado: (2014)